BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32441890)

  • 21. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
    Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
    Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of postoperative radiation after esophagectomy for esophageal cancer.
    Schreiber D; Rineer J; Vongtama D; Wortham A; Han P; Schwartz D; Choi K; Rotman M
    J Thorac Oncol; 2010 Feb; 5(2):244-50. PubMed ID: 20009774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
    Smith GL; Smith BD; Buchholz TA; Liao Z; Jeter M; Swisher SG; Hofstetter WL; Ajani JA; McAleer MF; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):482-9. PubMed ID: 19289262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradiotherapy and radiotherapy alone in patients with esophageal cancer aged 80 years or older based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Jingu K; Numasaki H; Toh Y; Nemoto K; Uno T; Doki Y; Matsubara H
    Esophagus; 2020 Jul; 17(3):223-229. PubMed ID: 32088786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.
    Sher DJ; Yan J; Day A; Sumer BD; Pham NL; Khan S; Zhu H
    Oral Oncol; 2019 Jan; 88():18-26. PubMed ID: 30616791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node-negative esophageal carcinoma.
    Gao HJ; Wei YC; Gong L; Ge N; Han B; Shi GD; Yu ZT
    Thorac Cancer; 2020 Sep; 11(9):2618-2629. PubMed ID: 32755068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer.
    Verma V; Surkar SM; Moreno AC; Lin C; Simone CB
    Cancer Med; 2018 May; 7(5):1604-1611. PubMed ID: 29603669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database.
    Zhang R; Jia M; Li P; Han J; Huang K; Li Q; Qiao Y; Xu T; Ruan P; Hu Q; Fan G; Song Q; Fu Z
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30277502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
    Xie L; Zhang Z
    Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis.
    Qi WX; Chen C; Zhao S; Chen J
    Int J Clin Oncol; 2022 Feb; 27(2):340-347. PubMed ID: 34731352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
    Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.
    Natesan D; Hong JC; Foote J; Sosa JA; Havrilesky L; Chino J
    Int J Gynecol Cancer; 2017 May; 27(4):794-804. PubMed ID: 28333840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of chemoradiotherapy versus radiotherapy alone in patients with intermediate-risk nasopharyngeal carcinoma: a population-based analysis.
    Xu YC; Chen KH; Liang ZG; Zhu XD
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1793-1802. PubMed ID: 36335249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in cancer-specific survival for locally advanced esophageal cancer after neoadjuvant chemoradiotherapy: A population-based analysis.
    Wang J; Ye C; Zhang C; Wang K; Hong F; Peng Q; Chen Z
    Front Surg; 2022; 9():989204. PubMed ID: 35965877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis.
    Li J; Gong Y; Diao P; Huang Q; Wen Y; Lin B; Cai H; Tian H; He B; Ji L; Guo P; Miao J; Du X
    Radiat Oncol; 2018 Jan; 13(1):12. PubMed ID: 29357883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.